Assignee
SIERRA ONCOLOGY INC
US·5 granted patents·5 pending applications·10 citations·filing 2017–2021
Top patents by PatentIndex Score
10 records- 0184USRE49445EN-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideSIERRA ONCOLOGY INC·Filed 2020·Granted Mar 7, 2023·1 cites·62 claims
- 0281USRE48285EN-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideSIERRA ONCOLOGY INC·Filed 2018·Granted Oct 27, 2020·2 cites·26 claims
- 0378US10245268B2Treatment of ACVR1-mediated diseasesSIERRA ONCOLOGY INC·Filed 2017·Granted Apr 2, 2019·3 cites·18 claims
- 0474US11596637B2CHK1 (SRA737)/PARPi combination methods of inhibiting tumor growthSIERRA ONCOLOGY INC·Filed 2018·Granted Mar 7, 2023·2 cites·21 claims
- 0570US11963962B2Platelet count-agnostic methods of treating myelofibrosisSIERRA ONCOLOGY INC·Filed 2019·Granted Apr 23, 2024·2 cites·21 claims
- 0645US2023078511A1Methods of using momelotinib to treat joint inflammationSIERRA ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 0741US2020397796A1Methods of treatment of cancer comprising chk1 inhibitorsSIERRA ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 0841US2022226338A1Methods of Treating Cancer Using CHK1 InhibitorsSIERRA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 0938US2022184091A1Methods of Treating Cancer with Chk1 InhibitorsSIERRA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1036US2020157638A1Biomarkers and patient selection strategiesSIERRA ONCOLOGY INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SIERRA ONCOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →